Document is current
Any future updates will be listed below
-
Authors
Liu, Dongxiao https://orcid.org/0000-0001-9656-8976
Posadas, Olivia
Mishra, Ashish K.
Mire, Mohamed M.
Pike, Mindy
Englund, Janet A. https://orcid.org/0000-0003-1134-4178
Kachikis, Alisa
Khurana, Surender https://orcid.org/0000-0002-0593-7965
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | U.S. Food and Drug Administration (Intramural funding)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (K23AI153390)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1 TR002319)
- License Information
-
More Information
Article History
Received: 26 March 2026
Accepted: 20 April 2026
First Online: 8 May 2026
Competing interests
: Dr. Kachikis reports on being a co-investigator on studies funded by Merck and Pfizer. Dr. Englund reported receiving grants/consultant fees from AstraZeneca, GSK, Merck, Meissa vaccines, Moderna, Pfizer, Shionogi, and Cidarra (DSMB). The rest of the authors have declared that no competing interests exist.
